Abhineet Kumar

The pharma firm, which had launched 14 products last year, is using social media to get into sub-therapies

Tata Sons' Chairman N Chandrasekaran has been vocal about simplifying cross holding within group firms since he took over last February

The growth has come at a time when GST implementation affected most Indian pharma companies including Abbott's MNC peers

While Lupin recorded a 10.6 per cent decline in its sales for the period, the largest, Sun Pharma, recorded a 17.4 per cent fall

The top of the chart is occupied by Ola cabs' Chinese peer Didi Chuxing, China Internet Plus is second on the list

Companies are sharing their strategy at JP Morgan Conference

The firm would require it to more than triple its CAGR of revenue to 18.5% for the next decade from 6%

Reliance Digital has established its presence in more than 100 cities and plans to expand further

In the Sept quarter, the Pirojsha Godrej-led firm recorded Rs 492 cr net sales, up 49% year-on-year

Sources said JSW Steel was likely to bid 'aggressively' for Bhushan Steel

It comes after the success of the Aadhaar-enabled fertiliser distribution system in collaboration with the Andhra govt

Q&A with Annaswamy Vaidheesh, MD of GSK Pharmaceuticals India

The business for distressed assets has almost been a non-starter in India

Chandra asked the companies to simplify their structure, become agile and cultivate accountability

Sun Pharma stock, the highest-valued Indian entity, dropped 13% to Rs 550

It started investing outside Singapore in 2002-03

Indian Hotels rolls back its multi-brand strategy to focus solely on luxury

Interview with the chairman, Piramal Group & Shriram Group

Almost half the states yet to notify rules, while others have watered down provisions of central Act

The New India Assurance Company also has a 1.7% stake in Hyderabad-based cigarette maker VST